vTv Therapeutics Inc (VTVT) — Cash Flow-to-Debt Ratio
vTv Therapeutics Inc (VTVT) has a Cash Flow-to-Debt Ratio of -0.26x as of June 2026, meaning its operating cash flow of $-2.29 Million could theoretically repay 0% of its total liabilities ($8.96 Million) in one year. See VTVT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
vTv Therapeutics Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for vTv Therapeutics Inc across 13 annual periods. For the full cash flow conversion analysis, see vTv Therapeutics Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for vTv Therapeutics Inc (2013–2025)
Year-by-year debt coverage analysis for vTv Therapeutics Inc. Check vTv Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.99x | $-25.25 Million | $25.46 Million | ▲ +6.1% |
| 2024 | -1.06x | $-25.31 Million | $23.96 Million | ▼ -63.6% |
| 2023 | -0.65x | $-19.08 Million | $29.57 Million | ▼ -16.0% |
| 2022 | -0.56x | $-15.25 Million | $27.40 Million | ▲ +70.5% |
| 2021 | -1.88x | $-19.31 Million | $10.25 Million | ▼ -15.1% |
| 2020 | -1.64x | $-18.00 Million | $11.00 Million | ▼ -28.8% |
| 2019 | -1.27x | $-23.02 Million | $18.11 Million | ▼ -332.7% |
| 2018 | -0.29x | $-26.86 Million | $91.41 Million | ▼ -18.0% |
| 2017 | -0.25x | $-44.56 Million | $178.96 Million | ▲ +24.9% |
| 2016 | -0.33x | $-48.21 Million | $145.44 Million | ▼ -52.1% |
| 2015 | -0.22x | $-36.95 Million | $169.50 Million | ▼ -262.4% |
| 2014 | -0.06x | $-30.78 Million | $511.76 Million | ▲ +53.9% |
| 2013 | -0.13x | $-41.68 Million | $319.24 Million | — |